Richard Lipman

Lose Weight with Belviq: No More Hunger with the Newest FDA Approved Weight Loss Medication (eBook, ePUB)

• Format: ePub

Produktbeschreibung

Belviq is the first new prescription drug for weight loss in the pass 20 years. Belviq was released by the FDA in early June 2013. It offers a new alternative for weight loss for the nearly one in three Americans who are considered obese. It is very effective in diabetics causing both weight loss and improvement in glucose control. Unlike any other diet medication it's designed both for weight loss and weight maintenance.

How does Belviq work?
The drug works by controlling appetite specifically by activating brain receptors for serotonin, a neurotransmitter that triggers feelings of satiety and satisfaction. Serotonin is also involved in mood; many antidepressant drugs work by preventing the reuptake of serotonin and keeping brain receptors bathed in the chemical. Researchers at Arena say their drug is designed to seek out only the serotonin receptors that affect appetite.

How effective is Belviq?
According to clinical trial data submitted by Arena to the FDA, nearly half of dieters without Type 2 diabetes who used the medication lost at least 5% of their starting weight or an average of 12 lbs. over a year, compared with 23% of those taking a placebo. For best results, dieters are advised to use the medication together with a healthy diet and exercise program
Who can take Belviq?

The FDA approved the medication for people who are obese (with a body mass index, or BMI, of 30 or higher) or who are overweight (with a BMI of 27 or above) and also have at least one weight-related health condition such as type 2 diabetes, hypertension and high blood lipids and cholesterol.

Are there any side effects?
The most common side effects of Belviq in non-diabetic patients are headache, dizziness, fatigue, nausea, dry mouth and constipation. These side effects occurred in 6% or less patients and most disappeared after a few days. Only 6% of subjects pulled out of the Belviq studies because of side effect. In patients with diabetes, side effects include low blood sugar, headache, back pain, cough and fatigue.

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, CY, CZ, D, DK, EW, E, FIN, F, GR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Richard Lipman MD
• Erscheinungstermin: 28. Juni 2013
• Englisch
• ISBN-13: 9781301384945
• Artikelnr.: 74341365

Autorenporträt

Richard L. Lipman M.D. has practiced internal medicine and endocrinology in his office in Miami, Fl for the past 30 years. As a board certified internist and board eligible endocrinologist he has treated more than 15,000 patients with weight and metabolism problems. Dr Lipman is a Charter Member of the American Association of Clinical Endocrinologists. He has treated hundreds of patients with HCG over the past two years.
Dr. Lipman received a BS degree in biochemistry and a MD in 1966 from the University of Pittsburgh. Dr. Lipman did his internship and residency in internal medicine at the University of Pittsburgh Medical Center Hospitals and a fellowship in Endocrinology at the University of Miami School of Medicine. While at the University of Miami, he authored and coauthored 15 publications in the areas of glucose and growth hormone metabolism. Dr. Lipman also spent two years at the United States Air Force School of Aerospace Medicine, where he was a staff member of the Endocrinology Division at the USAF Hospital in San Antonio, Texas. While in the Air Force, Dr. Lipman authored six publications on the effects of prolonged weightlessness on glucose and protein metabolism. Dr. Lipman is a staff member of Larkin and Cedars Hospital in Miami, a charter member of the American Association of Clinical Endocrinologists, and a member of the American Diabetes Association and the American Association of Bariatric Physicians.

He has treated more than 700 patients in his Miami, Fl office with the new Semaglutides-Ozempic and Wegovy and the even new Tirzepatides-Mounjaro and Zepbound. He relates his experience in his new book, Semaglutides: Once a Week Weight Loss Injections .